• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素通过促进帕金森病斑马鱼模型中的脂质代谢来改善异常的睡眠-觉醒行为。

Melatonin Ameliorates Abnormal Sleep-Wake Behavior via Facilitating Lipid Metabolism in a Zebrafish Model of Parkinson's Disease.

作者信息

Pang Meng-Zhu, Li Han-Xing, Dai Xue-Qin, Wang Xiao-Bo, Liu Jun-Yi, Shen Yun, Xu Xing, Zhong Zhao-Min, Wang Han, Liu Chun-Feng, Wang Fen

机构信息

Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institutes of Neuroscience, Soochow University, Suzhou, 215123, China.

出版信息

Neurosci Bull. 2024 Dec;40(12):1901-1914. doi: 10.1007/s12264-024-01299-8. Epub 2024 Sep 16.

DOI:10.1007/s12264-024-01299-8
PMID:39283564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625096/
Abstract

Sleep-wake disorder is one of the most common nonmotor symptoms of Parkinson's disease (PD). Melatonin has the potential to improve sleep-wake disorder, but its mechanism of action is still unclear. Our data showed that melatonin only improved the motor and sleep-wake behavior of a zebrafish PD model when melatonin receptor 1 was present. Thus, we explored the underlying mechanisms by applying a rotenone model. After the PD zebrafish model was induced by 10 nmol/L rotenone, the motor and sleep-wake behavior were assessed. In situ hybridization and real-time quantitative PCR were used to detect the expression of melatonin receptors and lipid-metabolism-related genes. In the PD model, we found abnormal lipid metabolism, which was reversed by melatonin. This may be one of the main pathways for improving PD sleep-wake disorder.

摘要

睡眠-觉醒障碍是帕金森病(PD)最常见的非运动症状之一。褪黑素具有改善睡眠-觉醒障碍的潜力,但其作用机制仍不清楚。我们的数据表明,只有当存在褪黑素受体1时,褪黑素才能改善斑马鱼PD模型的运动和睡眠-觉醒行为。因此,我们通过应用鱼藤酮模型探索其潜在机制。用10 nmol/L鱼藤酮诱导建立PD斑马鱼模型后,评估其运动和睡眠-觉醒行为。采用原位杂交和实时定量PCR检测褪黑素受体和脂质代谢相关基因的表达。在PD模型中,我们发现脂质代谢异常,而褪黑素可使其逆转。这可能是改善PD睡眠-觉醒障碍的主要途径之一。

相似文献

1
Melatonin Ameliorates Abnormal Sleep-Wake Behavior via Facilitating Lipid Metabolism in a Zebrafish Model of Parkinson's Disease.褪黑素通过促进帕金森病斑马鱼模型中的脂质代谢来改善异常的睡眠-觉醒行为。
Neurosci Bull. 2024 Dec;40(12):1901-1914. doi: 10.1007/s12264-024-01299-8. Epub 2024 Sep 16.
2
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
3
Melatonin for the promotion of sleep in adults in the intensive care unit.褪黑素用于促进重症监护病房成年患者的睡眠。
Cochrane Database Syst Rev. 2018 May 10;5(5):CD012455. doi: 10.1002/14651858.CD012455.pub2.
4
Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT.褪黑素与咪达唑仑用于择期全身麻醉手术患儿术前用药的比较:MAGIC非劣效性随机对照试验
Health Technol Assess. 2025 Jul;29(29):1-25. doi: 10.3310/CWKF1987.
5
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
6
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼:系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
7
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的身体锻炼:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
8
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.对于帕金森病患者,在接受丘脑底核刺激后,抑郁症状会对患者报告的疾病严重程度产生负面影响。
J Parkinsons Dis. 2025 Jun 26:1877718X251354933. doi: 10.1177/1877718X251354933.
9
Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.帕金森病日间嗜睡和睡眠障碍的药物干预:系统评价与荟萃分析
Parkinsonism Relat Disord. 2016 Jun;27:25-34. doi: 10.1016/j.parkreldis.2016.03.002. Epub 2016 Mar 4.
10
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.

引用本文的文献

1
Pro-Inflammatory Microglia Exacerbate High-Altitude-Induced Cognitive Impairment by Driving Lipid Droplet Accumulation in Astrocytes.促炎小胶质细胞通过促使星形胶质细胞中脂滴积累加重高原诱导的认知障碍。
Antioxidants (Basel). 2025 Jul 26;14(8):918. doi: 10.3390/antiox14080918.

本文引用的文献

1
Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho-1/Gpx4 pathway to prevent α-synuclein-induced ferroptosis in Parkinson's disease.褪黑素 MT1 受体通过调控 Sirt1/Nrf2/Ho-1/Gpx4 通路预防帕金森病中α-突触核蛋白诱导的铁死亡。
J Pineal Res. 2024 Mar;76(2):e12948. doi: 10.1111/jpi.12948.
2
Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson's Disease.正电子发射断层扫描成像在帕金森病突触功能障碍中的应用。
Neurosci Bull. 2024 Jun;40(6):743-758. doi: 10.1007/s12264-024-01188-0. Epub 2024 Mar 14.
3
Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.短链脂肪酸与帕金森病的关系:从病理学到临床的综述。
Neurosci Bull. 2024 Apr;40(4):500-516. doi: 10.1007/s12264-023-01123-9. Epub 2023 Sep 27.
4
Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder.褪黑素作为快速眼动睡眠行为障碍中的一种时间生物学/细胞保护剂。
Brain Sci. 2023 May 13;13(5):797. doi: 10.3390/brainsci13050797.
5
Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.帕金森病震颤的药物治疗再探。
J Parkinsons Dis. 2023;13(2):127-144. doi: 10.3233/JPD-225060.
6
Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease.褪黑素对帕金森病相关睡眠障碍的神经保护作用。
Antioxidants (Basel). 2023 Feb 6;12(2):396. doi: 10.3390/antiox12020396.
7
Regulatory role of melatonin in Notch1 signaling pathway in cerebral cortex of Aβ-induced Alzheimer's disease rat model.褪黑素在Aβ诱导的阿尔茨海默病大鼠模型大脑皮质Notch1信号通路中的调节作用
Mol Biol Rep. 2023 Mar;50(3):2463-2469. doi: 10.1007/s11033-022-08213-3. Epub 2023 Jan 5.
8
Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.药物基因组学——帕金森病个体化治疗的新前沿。
Curr Neuropharmacol. 2023;21(3):536-546. doi: 10.2174/1570159X21666221229154830.
9
Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson's Disease.糖脂代谢系统功能障碍与睡眠障碍可能导致帕金森病的发病与进展。
Int J Mol Sci. 2022 Oct 26;23(21):12928. doi: 10.3390/ijms232112928.
10
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations.XINDI 研究:一项随机、III 期临床试验,评估了沙芬酰胺作为左旋多巴添加治疗对中国有运动波动的帕金森病患者的疗效和安全性。
CNS Drugs. 2022 Nov;36(11):1217-1227. doi: 10.1007/s40263-022-00958-6. Epub 2022 Nov 8.